[Alltek] Announcement of Shareholder Meeting Resolution to Release Directors and Representatives from Non-Compete Obligations

1. Date of shareholder meeting resolution: May 20, 2026 2. Names and titles of directors permitted to engage in competitive behavior: (1) Corporate Director: Qisda Corporation (2) Corporate Director: Xue Daolong, Representative of Qisda Corporation (3) Corporate Director: Hong Qiujin, Representative of Qisda Corporation (4) Independent Director: Ye Huixin (5) Independent Director: Zhu Xuanlian 3. Scope of permitted competitive behavior: (1) Qisda Corporation: Chairman of Qisda Vietnam Corporation, Director of GeneReach Biotechnology, Chairman of DFI, Director of AUO, etc. (2) Xue Daolong: Chairman of Qisda Electronic, Director of Etron Technology, etc. (3) Hong Qiujin: Representative of Shanghai Felte Technology, Representative of BenQ (Nanjing) Hospital, etc. 4. Duration of permission: During the tenure of their position as Alltek directors or their representatives. 5. Resolution status: Approved by two-thirds or more of the voting rights present, representing more than half of the total issued shares. 6. Directors involved in Mainland China operations: Hong Qiujin, representative of Qisda Corporation. 7. Mainland China entities and roles: Representative for Shanghai Felte Technology, Nanjing BenQ Hospital, etc. 8. Locations of Mainland operations: Shanghai, Nanjing, Suzhou. 9. Business scope in Mainland China: Sales of medical equipment, hospital management, R&D in biotechnology. 10. Impact on company's financial and business operations: None.